Mustang Bio Stock Current Liabilities
| MBIO Stock | USD 0.22 0.01 4.76% |
Mustang Bio fundamentals help investors to digest information that contributes to Mustang Bio's financial success or failures. It also enables traders to predict the movement of Mustang Stock. The fundamental analysis module provides a way to measure Mustang Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mustang Bio stock.
As of the 21st of October 2024, Total Current Liabilities is likely to drop to about 9.2 M. In addition to that, Non Current Liabilities Total is likely to drop to about 2.1 M. Mustang | Current Liabilities |
Mustang Bio Company Current Liabilities Analysis
Mustang Bio's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Mustang Bio Current Liabilities | 3.93 M |
Most of Mustang Bio's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mustang Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Mustang Current Liabilities Driver Correlations
Understanding the fundamental principles of building solid financial models for Mustang Bio is extremely important. It helps to project a fair market value of Mustang Stock properly, considering its historical fundamentals such as Current Liabilities. Since Mustang Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Mustang Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Mustang Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
Mustang Current Liabilities Historical Pattern
Today, most investors in Mustang Bio Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Mustang Bio's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current liabilities growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Mustang Bio current liabilities as a starting point in their analysis.
Mustang Bio Current Liabilities |
| Timeline |
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
Mustang Total Current Liabilities
Total Current Liabilities |
|
In accordance with the recently published financial statements, Mustang Bio has a Current Liabilities of 3.93 M. This is 99.78% lower than that of the Biotechnology sector and 99.28% lower than that of the Health Care industry. The current liabilities for all United States stocks is 99.95% higher than that of the company.
Mustang Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mustang Bio's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Mustang Bio could also be used in its relative valuation, which is a method of valuing Mustang Bio by comparing valuation metrics of similar companies.Mustang Bio is currently under evaluation in current liabilities category among its peers.
Mustang Fundamentals
| Return On Equity | -11.91 | ||||
| Return On Asset | -1.05 | ||||
| Current Valuation | 4.91 M | ||||
| Shares Outstanding | 36.39 M | ||||
| Shares Owned By Insiders | 7.56 % | ||||
| Shares Owned By Institutions | 2.31 % | ||||
| Number Of Shares Shorted | 382.14 K | ||||
| Price To Earning | (11.40) X | ||||
| Price To Book | 31.75 X | ||||
| EBITDA | (48.5 M) | ||||
| Net Income | (51.6 M) | ||||
| Cash And Equivalents | 107.37 M | ||||
| Cash Per Share | 1.01 X | ||||
| Total Debt | 2.5 M | ||||
| Debt To Equity | 0.35 % | ||||
| Current Ratio | 9.96 X | ||||
| Book Value Per Share | (0.24) X | ||||
| Cash Flow From Operations | (49.48 M) | ||||
| Short Ratio | 0.64 X | ||||
| Earnings Per Share | (2.72) X | ||||
| Target Price | 10.0 | ||||
| Number Of Employees | 80 | ||||
| Beta | 1.95 | ||||
| Market Capitalization | 8.09 M | ||||
| Total Asset | 17.74 M | ||||
| Retained Earnings | (380.97 M) | ||||
| Working Capital | (4.03 M) | ||||
| Current Asset | 42.37 M | ||||
| Current Liabilities | 3.93 M | ||||
| Net Asset | 17.74 M |
About Mustang Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mustang Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mustang Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mustang Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Mustang Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Mustang Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mustang Bio will appreciate offsetting losses from the drop in the long position's value.Moving together with Mustang Stock
| 0.9 | VALN | Valneva SE ADR | PairCorr |
| 0.82 | DYAI | Dyadic International | PairCorr |
| 0.86 | ERNA | Eterna Therapeutics | PairCorr |
Moving against Mustang Stock
| 0.88 | GILD | Gilead Sciences | PairCorr |
| 0.75 | INBX | Inhibrx Symbol Change | PairCorr |
| 0.7 | GNFT | Genfit | PairCorr |
| 0.67 | ZURA | Zura Bio Limited | PairCorr |
| 0.64 | BMY | Bristol Myers Squibb | PairCorr |
The ability to find closely correlated positions to Mustang Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Mustang Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Mustang Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Mustang Bio to buy it.
The correlation of Mustang Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mustang Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mustang Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Mustang Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Mustang Bio Piotroski F Score and Mustang Bio Altman Z Score analysis. To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.72) | Revenue Per Share (0) | Return On Assets (1.05) | Return On Equity (11.91) |
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mustang Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.